Financial News
Latest News about Food and Drug Administration
Recent news which mentions Food and Drug Administration
FDA Reviews Kidney Disease Drug From Apellis Pharmaceuticals
April 01, 2025
From Benzinga
FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery
February 24, 2025
From Benzinga
Ozempic Receives FDA Approval To Treat Kidney Disease
January 28, 2025
From Benzinga
From Benzinga
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
January 15, 2025
From Benzinga
RFK Jr.'s Anti-Science Views 'Could Be Very Dangerous' For Psychedelics Movement Says Michael Pollan
December 03, 2024
From Benzinga
Kennedy's War On Food Dyes Could Be Coming To Your Breakfast Table
November 22, 2024
From Benzinga
From Benzinga
From Benzinga
Massachusetts Votes Down Psychedelic Therapy After Hard-Fought Legalization Campaign, What's Next?
November 06, 2024
Tickers
NEWS
From Benzinga
From Benzinga
Trump Says Robert Kennedy Jr. Can Run Wild On Health And Food: 'I'm Going To Let Him Go Wild On The Medicines'
October 27, 2024
From Benzinga
McDonald's Rivals Burger King, Yum Brands Remove Onions From Menus Amid Quarter-Pounder E.Coli Scare
October 24, 2024
From Benzinga
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
October 23, 2024
From Benzinga
Robert Kennedy Jr: Trump Wants Him To Help Pick CDC, FDA, and NIH Leaders — 'Unravel The Capture Of Agencies By Corrupt Influence'
September 18, 2024
From Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
From Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
From Benzinga
Moxy: The Short, Intense Psychedelic High Sweeping The Globe
September 10, 2024
From Benzinga
From Benzinga
Tags
MDMA/assisted therapy
Psychedelic Research
Multidisciplinary Association for Psychedelic Studies (MAPS)
From Benzinga
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
August 09, 2024
From Benzinga
Senators Press FDA To Approve MDMA As PTSD Treatment, Stressing US Vets' Suicide Rates As Aug 11 Decision Looms
August 06, 2024
Tickers
NEWS
From Benzinga
FDA Accuses Companies Of Marketing Cannabis Products To Children Amid Debate On Hemp Cannabinoids Ban
July 17, 2024
From Benzinga
From Benzinga
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
From Benzinga
From Benzinga
EXCLUSIVE: FDA Advisors Say Regulatory Certainty Needed For Cannabis Market
September 28, 2023
From Benzinga
Congressional Research Service Foresees Potential DEA Endorsement Of Marijuana Rescheduling
September 14, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
